Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Neuromodulation
•
Ketamine
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Related Questions
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
How do you treat postpartum obsessive-compulsive disorder?
Are there any potentially successful pharmacologic interventions (instead of CBT or behavioral interventions alone) for Schizoid personality disorder?
How do you discuss the mechanism and potential benefits of meditation with your patients?
When do you decide to use liothyronine (T3) for augmentation in treatment for treatment-resistant depression and how do you implement it?
How do you handle elevated blood calcium levels from lithium?
How do you cross-taper when switching from an SSRI to an SNRI?
How do you work with patients with somatic symptom disorder who do not have a stable medical team?
Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (prn) if/when symptoms develop?
